Taltz (ixekizumab) is a prescription medication that is used to treat plaque psoriasis, psoriatic arthritis, and ankylosing spondylitis. It is an injectable biologic medication that works by targeting and inhibiting a substance known as interleukin-17A, which is involved in inflammation.
Taltz is generally administered once every two weeks as an injection into the skin or taken once every four weeks as a subcutaneous injection. The dosage is determined based on the patient’s individual medical history and response to treatment.
Clinical studies have demonstrated that Taltz is effective in treating moderate to severe plaque psoriasis in both adult patients who are candidates for systemic therapy or phototherapy. Taltz has also shown positive results in treating psoriatic arthritis and ankylosing spondylitis which are same inflammatory conditions that chronic psoriasis patients may also have.
Taltz is administered using the Taltz autoinjector, or a prefilled syringe following the technique and instruction given by the healthcare provider.
Like any medication, taking Taltz can lead to side effects. Common side effects include upper respiratory tract infections, injection site reactions, and headache. Other serious side effects may include allergic reactions, infections, and worsening of inflammatory bowel diseases such as Crohn’s and ulcerative colitis. Before engaging with the therapy, the patients should make sure that they do not have tuberculosis, hepatitis B, or any other infection. Thus, patients should be carefully evaluated and monitored throughout the course of treatment.
In conclusion, Taltz (ixekizumab) is a valuable treatment option for people with moderate to severe plaque psoriasis, psoriatic arthritis and ankylosing spondylitis; chronic conditions linked to inflammation. The medication mainly works by inhibiting a protein known as interleukin-17A which is involved in inflammation. Taltz offers benefits to many patients who are candidates for systemic therapy or phototherapy and has demonstrated to improve the condition and quality of life of psoriasis patients. As with any medication, patients should be aware of the risks associated with Taltz and should discuss these with their healthcare providers prior to initiating therapy.
EthanCaresSkin –
I was diagnosed with moderate-to-severe psoriasis last year, and my dermatologist started me on Taltz right away. I noticed dramatic improvement after just a few doses. The itching stopped, the scaling reduced, and now my plaques are barely visible. I appreciate how quickly it works compared to other biologics I’ve tried. If you’re hesitant, talk to your doctor—Taltz has been life-changing for me.
Jasmine L. –
Taltz didn’t just help my skin—it also helped my joints. I’ve been dealing with both psoriasis and psoriatic arthritis, and the swelling and stiffness in my hands used to make daily tasks difficult. Since starting Taltz, I’ve had major improvement in joint pain and almost total skin clearance. I feel like a different person. So grateful for this medication.
Mark D. –
I’ve had severe plaque psoriasis since I was a teenager, and nothing—topicals, light therapy, even other biologics—got me completely clear. Taltz changed that. Within three months, my skin was 95% clear, and I couldn’t believe it. The injections are easy to do at home, and I’ve had minimal side effects. This medication gave me back my confidence. I wore shorts last summer for the first time in years.